A Possible Solution To Europe's Pharma Financing Problem

Recession and consequent cuts in public pharmaceutical expenditure in Europe have slowed down the access to market of pharmaceutical innovations in the last few years. As a solution, public health authorities...

Already a subscriber? Click here to view full article